ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine
January 04, 2022Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to... -
FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16- and 17-year-olds
December 10, 2021Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 16 and 17 years of age at least six... -
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response
December 08, 2021Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries. -
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
November 26, 2021Pfizer Inc. and BioNTech SE today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age... -
FDA In Brief: FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution, Making Vaccine More Widely Available
May 21, 2021Making COVID-19 vaccines widely available is key to getting people vaccinated and bringing the pandemic to an end. Pfizer Inc. submitted data to the FDA to support storage of undiluted
Pharma Sources Insight January 2025
